Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with di...

von Coelewij, Leda
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2024)